Standout Papers
- Hepatocellular carcinoma (2021)
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update (2021)
- Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis (2018)
- Epidemiology and surveillance for hepatocellular carcinoma: New trends (2020)
- Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients (2018)
- Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis (2019)
- AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma (2023)
- Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis (2009)
- Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis (2014)
- Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study (2017)
- A Primer on Effectiveness and Efficacy Trials (2014)
- Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice (2015)
- Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis (2017)
- Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy (2023)
- Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer (2022)
- Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction (2019)
- HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis (2022)
- Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores (2019)
- Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta‐Analysis (2020)
- Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment (2023)
- Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma (2024)
- Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era? (2022)
- Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology (2023)
- Breakthroughs in Hepatocellular Carcinoma Therapies (2023)
Immediate Impact
6 by Nobel laureates 4 from Science/Nature 111 standout
Citing Papers
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Alcohol-associated liver disease
2024 Standout
Works of Amit G. Singal being referenced
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
2022 Standout
Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction
2019 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Amit G. Singal | 15656 | 13645 | 5193 | 484 | 27.2k | |
| Jorge A. Marrero | 19028 | 15813 | 3453 | 204 | 27.6k | |
| Katherine A. McGlynn | 6563 | 7216 | 5565 | 329 | 23.7k | |
| Winnie Yeo | 7117 | 5846 | 6315 | 417 | 17.2k | |
| Andrew K. Burroughs | 28917 | 23578 | 3162 | 498 | 37.9k | |
| Norihiro Kokudo | 16121 | 7068 | 7081 | 718 | 25.4k | |
| Paul B.S. Lai | 6157 | 4704 | 5978 | 428 | 20.6k | |
| Michaël Abécassis | 15020 | 8004 | 2548 | 321 | 23.0k | |
| Henry Lik‐Yuen Chan | 15891 | 20322 | 1924 | 436 | 27.4k | |
| Grace Lai–Hung Wong | 13699 | 19470 | 1718 | 539 | 26.0k | |
| Alan P. Venook | 5085 | 3480 | 9629 | 361 | 17.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...